Geninus Officially Certified for DTC Genetic Testing... "Promoting Business Partnerships with Kakao Healthcare and Others"
Verification of Personal Genetic Testing Capabilities through DTC Certification
Introducing Various Data Utilization Projects
Geninus, a genome analysis specialist company, announced on the 4th that it has officially obtained certification as a genetic testing institution under the ‘Direct-to-Consumer (DTC) Genetic Testing Competency Certification System’ implemented by the Ministry of Health and Welfare starting this year.
DTC genetic testing refers to genetic tests that consumers can request directly from genetic testing institutions without visiting medical institutions. Through this, consumers can easily undergo genetic testing and manage their health according to their genetic characteristics.
In South Korea, DTC genetic testing is available through genetic testing institutions that have received prior approval for test items, focusing on wellness items for disease prevention and health management such as nutrition, skin and hair, lifestyle, and personal traits.
The DTC certification system is a program implemented under the supervision of the Ministry of Health and Welfare to ensure safe genetic testing. After a three-year pilot project, it has been officially implemented since the end of 2022.
Geninus underwent the DTC certification review in the first half of this year and was evaluated on various criteria including test accuracy, delivery of test results, and personal information protection, ultimately obtaining official certification as a DTC genetic testing institution. The certification is valid for three years, and certified institutions can safely provide DTC genetic testing services for the certified items.
A company representative explained, "We are currently pursuing business partnerships with numerous healthcare solution companies," and added, "We expect substantial orders starting from the second half of this year and are expanding our testing infrastructure in preparation." They emphasized, "Based on the verified testing capabilities through DTC certification, we will introduce differentiated content and business models."
Going forward, Geninus plans to continuously and aggressively expand new test items through additional conformity assessments.
Geninus CEO Park Woong-yang stated, "As an officially certified genetic testing institution, Geninus will take the lead in the proper utilization of genomic data and introduce various businesses that can enhance the value of data utilization," and added, "We will continue to provide various forms of solutions that enable optimal health management according to individual genomic characteristics by analyzing the 'genes within us.'"
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Last year, Geninus signed a business agreement with Kakao Healthcare for DTC genetic testing services. Earlier this year, the company established a DTC business team within its genome business division and is striving to build a market position in the DTC field.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.